102 research outputs found
Electrochemical Reduction of Intermediates in the Vitamin B6 Production. II. Reduction of 2-Methoxymethyl-3-nitro-4-methyl- 5-cyano-6-chloropyridine
2-Methoxymethyl-3-nitro-4-methyl-5-cyano-6-chloropyridine
(I) was reduced on a mercury-pool in an electrolytic cell with a
diaphragm. A mixture of acetic and hydrochloric acid was used
as catholyte and diluted hydrochloric acid as anolyte. Compound
I was reduced at - 0.5 V to 2-methoxymethyl-3-amino-4-methyl-
5-cyano-6-chloropyridine (II) (yield 67-820/o). Compound II was
reduced at - 0.9 V to 2-methoxymethyl-3-amino-4-methyl-5-
cyanopyridine (Ill) (yield 54-83-0/o). Compound III was reduced
at -1.1 V to 2,4-dimethyl-3-amino-5-cyanopyridine (IV) (yield
48-660/o Compound IV was reduced at constant current density
to 2,4-dimethyl-3-amino-5-aminomethylpyridine (V) (yield 82,40/o).
Polarographic waves of I, II, and III are defined and character of
limiting currents was determined according to the usual criteria
Electrochemical Reduction of Intermediates in the Vitamin B6 Production. II. Reduction of 2-Methoxymethyl-3-nitro-4-methyl- 5-cyano-6-chloropyridine
2-Methoxymethyl-3-nitro-4-methyl-5-cyano-6-chloropyridine
(I) was reduced on a mercury-pool in an electrolytic cell with a
diaphragm. A mixture of acetic and hydrochloric acid was used
as catholyte and diluted hydrochloric acid as anolyte. Compound
I was reduced at - 0.5 V to 2-methoxymethyl-3-amino-4-methyl-
5-cyano-6-chloropyridine (II) (yield 67-820/o). Compound II was
reduced at - 0.9 V to 2-methoxymethyl-3-amino-4-methyl-5-
cyanopyridine (Ill) (yield 54-83-0/o). Compound III was reduced
at -1.1 V to 2,4-dimethyl-3-amino-5-cyanopyridine (IV) (yield
48-660/o Compound IV was reduced at constant current density
to 2,4-dimethyl-3-amino-5-aminomethylpyridine (V) (yield 82,40/o).
Polarographic waves of I, II, and III are defined and character of
limiting currents was determined according to the usual criteria
Potential Years of Life Lost Due to Premature Mortality from Cancer in Karlovac County (Croatia), 2006ā2010
The aim of this paper was to estimate cancer burden in the Karlovac County using potential years of life lost due to
cancer and contribute to setting priorities in cancer control at the local level. Potential years of life lost (PYLL) is an important
public health mortality indicator that goes into the category of social indicators and has a great role in the process
of health care planning in defi ning priorities for the prevention of premature death. In this paper PYLL is defi ned as the
number of years of life lost by persons who died in the age of 1ā75. In the period 2006ā2010 there were 4118 death in Karlovac
County in the 1ā75 age group which makes 48204 potential years of life lost, where 33856.5 (70.24%) PYLL referred
to men, and 14347.5 (29.76%) PYLL to women. Cancer was responsible for the largest proportion of premature death
(33.17%), in which 62.90% of premature death referred to men and 37.10% to women. Lung cancer was the leading cause
of premature death due to cancer for men (31.04% of PYLL due to cancer) and the breast cancer for women (17.95% PYLL
due to cancer). In the observed period cancer caused the shortening of the average life span of 11.9 years, out of which the
biggest loss was caused by melanoma (18.7 years). Population health measures based on PYLL are useful for measuring
and monitoring the impact of local efforts to reduce premature mortality
Dipyridamole stress echo ā the next step in evolution of stress imaging in the Echocardiography Laboratory at the Äakovec County Hospital
Introduction: Stress echocardiography is the combination of 2D echocardiography with physical, pharmacological or electrical stress. The diagnostic endpoint of the detection of myocardial ischemia is the induction of a transient change in regional function during stress.1 Myocardial ischemia results in a typical ācascadeā of events in which the various markers are hierarchically ranked in a well-defined time sequence. Flow heterogeneity between subendocardial and subepicardial perfusion is the forerunner of ischemia, followed by metabolic changes, alteration in regional mechanical function, and only at a later stage by electrocardiographic (ECG) changes, global left ventricular dysfunction (LV) and pain.2 Wall motion and perfusion or coronary flow reserve (CFR) changes are highly accurate, and more accurate than ECG changes for detection and location of underlying coronary artery disease. However, wall motion is more specific and requires ischemia; perfusion changes are more sensitive and may occur in the absence of true ischemia (microvascular disease, or LV hypertrophy).1 The three most common ischemic stressor are exercise, dobutamine, and vasodilators (dipyridamole, adenosine). They are equally potent for inducing wall abnormalities in the presence of
a critical epicardial coronary artery stenosis. Dobutamine and exercise manly act through increased myocardial oxygen demand. Vasodilators act by stimulating A2 adenosinergic receptors present on the endothelial
and smooth muscle cells of coronary arterioles and induce ischemia due to reduced subendocardial flow supply subsequent to inappropriate arteriolar vasodilatation and steal phenomena.1 Dipyridamole was the first pharmacological stress agent used for the diagnosis of coronary
artery disease, with a pioneering indication proposed in Europe for the identification of ischemia during 12-lead ECG3, and later in the USA by Lance Gould as hyperemic stress perfusion imaging.4 Dipyridamole stress echocardiography pioneered in the year of 1985 (Picano
et al). The safety record of high dose dipyridamole is well established on the basis of large scale multicentric studies with data from thousands of patients. The incidence of major complications, i.e. myocardial infarction, atrioventricular block, cardiac asystole, sustained ventricular
tachycardia, is about 1/1500 cases. The mortality rate is about 1/10000 cases, similar to that of the exercise stress test. Dipyridamole has a better safety profile than when stress testing with dobutamine, where the incidence of major adverse reactions is about 1/300 studies.5 Many
centers from 1988 until today, have used high doses administered in a short time (syringe-based infusion of 0.84 mg/kg). Later, some studies were reproduced with these doses, and today, most centers worldwide use high dose delivered in 4-6 min.6 Center experience: In 2017 we started to perform stress echocardiography in Äakovec County Hospital. The first method was exercise echocardiography using treadmill protocol, with imperative do accomplish postexercise imaging as soon as possible (<1 min from the cessation of exercise) where patient moved immediately from treadmill to imaging bed. With this method we have information from exercise stress testing combined with echocardiographic wall motions analysis to make final interpretation. The second method and most used until recently in our echo lab is standard dobutamine stress protocol, starting with 5 ug/kg/min and increasing 10, 20, 30 and 40 ug/kg/min. If no endpoint is reached, atropine, usually in dose 0.25 mg, is added to maximal dobutamine dose infusion. We are using this method for coronary disease detection, but also low dose protocol, to asses myocardial viability, valvular pathology (low-flow aortic stenosis) and other indications. Recently we started vasodilator stress echocardiography using dipyridamole, and until today, we performed a test on 15 patients. Protocol diagram is showed in Figure 1. The dipyridamole dose employed for stress testing was 0.84 mg/kg administered in short time (syringe-based infusion at a rate of 0.21 mg/kg/min during 4 minutes). A fast protocol is embraced because is known that high dose protocols in short time causes a three- to fourfold increase in coronary blood flow in normals and give best sensitivity and specificity for coronary pathology detection7. Peak vasodilatation occurs 1 to 2 minutes after the end of infusion and the dipyridamole elimination half-time is 40 minutes which enables us enough time for imaging in the period of maximum stress. After image completion we give the antidote aminophylline (blocks adenosine receptors) even in negative cases. The antidote can also be used for emergent reversal of adverse dipyridamole-related events which we have not encountered in this limited series of tests. If technically feasible due to image quality, we perform measurement of coronary
flow reserve in mid to distal left anterior descending artery (LAD) using pulse doppler (Figure 2 and Figure 3) before and after vasodilatation.
CFR in many cases adds additional diagnostic value when combined with conventional wall motion analysis. Another tool to increase diagnostic accuracy, especially when image quality is impaired, are contrast agents (i.e. Optison) which help to delineate endocardial borders. All caffeine-containing foods (coffee, tea, chocolate, bananas, cola drinks) should be avoided for 12 hours before test and all theophylline- containing drugs (aminophylline) should be discontinued for at least 24 hours before test. Very low dose protocols can be used (0.28 ug/kg) to identify myocardial viability and have high specificity (higher than dobutamine) but lower sensitivity8. Absolute contraindications for dipyridamole stress test are active bronchospasm, 2nd or 3rd degree AV block and systolic blood pressure <90 mmHg. Relative contraindications are methylxanthine use and remote history of restrictive airway disease.
Conclusion: Dipyridamole stress echocardiography can be used as a preferred stress test for the detection of coronary artery disease
in patients unable to exercise and with contraindications to dobutamine (tachyarrhythmias, uncontrolled blood pressure). It is technically easier than exercise or dobutamine stress tests since image quality is less degraded by tachycardia, hyperventilation and hypercontractility. The test is equally accurate in comparison with dobutamine, but technically easier and safer9. In the future, dipyridamole test is planned to be the default method for pharmacological stress in our laboratory supported with contrast agents when necessary. Contrast perfusion stress echocardiography is the next planned step in years to come
Tumori i pseudotumori orbite
Twenty-four orbital tumors and 4 pseudotumors diagnosed in biopsy material among 596 ophthalmic tumors examined during the 1998-2003 period are presented according to patient age and sex, tumor histology and immunohistochemistry. The most common orbital tumors were lipomas, meningiomas and lymphomas, with a peak incidence in the seventh decade of life. Most orbital tumors of childhood are distinguished from those occurring in adults. Most pediatric orbital tumors are benign (developmental cysts, capillary hemangioma, hamartoma), with a peak incidence in the first decade of life. Orbital tumors show a bimodal age distribution. Benign orbital tumors are more common than the malignant ones. Rhabdomyosarcoma (embryonal type) is the most common orbital malignancy in childhood, and lymphoma in adults. Orbital pseudotumors are a term that has been widely accepted to describe inflammatory lesions of the orbital tissue with a mixed inflammatory infiltrate with a varying grade of fibrosis. Histologic classification of orbital pseudotumors is presented. Orbital pseudotumors occur predominantly in older individuals and are infrequent in children and young individuals. These imply a nonspecific inflammatory process of unknown etiology, and have been included as part of the differential diagnosis of orbital tumors.Opisuju se 24 tumora i 4 pseudotumora orbite prema njihovim histoloÅ”kim i imunohistokemijskim obilježjima, dobi i spolu, dijagnosticirani u biopsijskom materijalu meÄu 624 oftalmiÄnih tumora u razdoblju od 1998. do 2003. godine. NajÄeÅ”Äi orbitalni tumori bili su lipomi, meningeomi i limfomi s vrÅ”nom uÄestaloÅ”Äu u sedmom desetljeÄu života. VeÄina orbitalnih tumora djeÄje dobi razlikuje se od tumora koji se javljaju u odraslih. Tumori djeÄje dobi veÄinom su benigni (ciste, kapilarni hemangiomi i hamartomi) s vrÅ”nom uÄestaloÅ”Äu u prvom desetljeÄu života. Orbitalni tumori imaju bimodalni oblik rasporeda uÄestalosti. NajÄeÅ”Äi zloÄudni tumor djeÄje dobi je rabdomiosarkom (embrionalni tip), a u odraslih limfom. Orbitalni pseudotumori su prihvaÄen izraz koji opisuje lezije orbitalnog tkiva s mijeÅ”anim upalnim infiltratom s razliÄitim stupnjem fibroze. Prikazana je histoloÅ”ka klasifikacija orbitalnih pseudotumora. Orbitalni pseudotumori javljaju se pretežito u starijih osoba, a rijetko u djece i mladih. To su nespecifiÄne upale nepoznatog uzroka koje su ukljuÄene kao dio diferencijalne dijagnoze orbitalnih tumora
Neuroblastoma in children
Neuroblastom je najÄeÅ”Äi ekstrakranijalni solidni tumor djeÄje dobi i Äetvrti po redu od svih pedijatrijskih tumora. PotjeÄe od neuroblasta, pluripotentnih stanica simpatiÄkog živÄanog sustava. NajÄeÅ”Äe se primarni tumor naÄe u abdomenu, zatim u prsnom koÅ”u, a vrat i zdjelica su rjeÄe lokalizacije. Bolest se u veÄine djece prezentira s palpabilnom abdominalnom masom kao prvim znakom bolesti. Ostali znakovi i simptomi bolesti su: kaÅ”alj, dispneja, Hornerov sindrom, disfunkcija mokraÄnog mjehura i crijeva, neuroloÅ”ki ispadi, bolovi u kostima, orbitalne ekhimoze, povremene temperature, anemija, generalizirana bol itd. Nažalost se, otprilike 70-80% pacijenata starijih od 18 mjeseci prezentira s metastatskom boleÅ”Äu u limfnim Ävorovima, jetri, koži, kostima i koÅ”tanoj srži. U dijagnostici neuroblastoma koriste se laboratorijski testovi i slikovne metode za evaluaciju primarne bolesti i njene diseminacije. Dob, stadij i bioloÅ”ke karakteristike tumora su važni prognostiÄki Äimbenici koji se koriste u stratifikaciji rizika i u odabiru odgovarajuÄeg lijeÄenja. Razlike u ishodu bolesti meÄu pacijentima s neuroblastomom su upeÄatljive. Pacijenti s niskim i intermedijarnim rizikom bolesti imaju odliÄnu prognozu i ishod. MeÄutim, oni s visokim rizikom bolesti i dalje imaju vrlo loÅ”u prognozu usprkos intenzivnoj terapiji. Äak i s primjenom visokih doza kemoterapije i autolognom transplantacijom matiÄnih stanica, manje od polovice pacijenata se izlijeÄi.Neuroblastoma is the most common extracranial solid tumor in children and fourth of all pediatric cancers. It originates from neuroblasts, pluripotent cells of the sympathetic nervous system. The majority of primary tumors occur in the abdomen, then in thorax, seldom in neck and pelvis. Neuroblastoma usually presents with palpable abdominal mass as the first sign of the disease. Other signs and symptoms include: cough, dyspnea, Horner's syndrome, bladder and bowel dysfunction, neurologic disorders, bone pain, orbital ecchymosis, occasional temperature, anemia, generalized pain, etc. Unfortunately, approximately 70-80% of patients older than 18 months present with metastatic disease, usually in the lymph nodes, liver, bone, and bone marrow. The diagnosis of neuroblastoma consists of lab tests and imaging techniques for the evaluation of the primary tumor and its extension. Age, stage and biological features encountered in tumor are important prognostic factors and are used for risk stratification and treatment assignment. The differences in outcome for patients with neuroblastoma are striking. Patients with low- and intermediate-risk neuroblastoma have excellent prognosis and outcome. However, those with high-risk disease continue to have very poor outcomes despite intensive therapy. Less than half of these patients are cured, even with the use of high-dose therapy followed by autologous bone marrow and stem cell rescue
Report on the compliance of concrete with structural design requirements
DonoÅ”enjem novog TehniÄkog propisa za betonske konstrukcije mijenjaju se postupak i podaci za donoÅ”enje zavrÅ”ne ocjene kvalitete betona ugraÄenog u betonsku konstrukciju. UsporeÄeni su postupci prema starom i novom propisu. Vidi se da se postupak po starom propisu bazira viÅ”e na rezultatima ispitivanja na mjestu ugradnje, a po novom propisu na procedurama i dokumentiranom upravljanju procesima. DonoÅ”enje je zavrÅ”ne ocjena kvalitete ugraÄenog betona po novom propisu zahtjevnije.The approval of the new Technical Regulations for concrete structures has brought some changes in the procedure and the data for the final quality assessment of concrete placed in concrete structures. Procedures based on the new and old regulations are compared. It can be seen that the procedure based on the old regulations is more reliant on in-situ test results, while new regulations rely more on the procedures and on the documented management of procedures. The final assessment of concrete quality after placing is more demanding when based on the new regulations
Development of a capillary electrophoretic method for simultaneous determination of gemcitabine and its impurity
Gemcitabin, 2',2'-difluoro-2'-deoksicitidin, antimetabolit pirimidina, je antineoplastiÄni lijek koji se koristi u lijeÄenju brojnih uznapredovalih ili metastatskih karcinoma kao monoterapija ili u kombinaciji s drugim citostaticima, ovisno o indikaciji.
Cilj je ovog istraživanja bio razviti novu, brzu, jednostavnu i ekoloÅ”ki prihvatljivu kapilarnoelektroforetsku metodu za istovremenu analizu gemcitabina i njegovog oneÄiÅ”Äenja cizotina. Kao prikladna tehnika odabrana je kapilarna elektroforeza kao "zelena" alternativa veÄ razvijenoj HPLC metodi za odreÄivanje sadržaja gemcitabina i odreÄivanje oneÄiÅ”Äenja uvrÅ”tenoj u 8. izdanje Europske farmakopeje.
Analiza je vrÅ”ena u kapilari duljine 35 cm (27 cm) pri temperaturi od 25 Ā°C, na valnoj duljini detekcije od 275 i 237 nm. Tijekom razvoja nove metode ispitane su razliÄite vrste radnih pufera: boratni (pH 9,3), fosfatni (pH 7,0) i acetatni (pH 3,0). Na temelju rezultata eksperimenata najbolji puferom pokazao se fosfatni pufer (pH 7,0), dok je bolje razdvajanje i oblik pikova postignut dodatkom veÄe koncentracije SDS-a. Optimalnim se pokazala 50 mM koncentracija SDS-a. Ispitan je i utjecaj napona na vrijeme analize te razluÄivanje izmeÄu analita. Kod napona od 10 kV postignuto je bolje razdvajanje gemcitabina i citozina. MeÄutim, primjenom nižeg napona produljuje se vrijeme putovanja analita kroz kapilaru pa je potrebno voditi raÄuna o tome da je razluÄivanje izmeÄu analita Å”to bolje, no istovremeno uz Å”to kraÄe vrijeme analize.
Predlaže se daljnja optimizacija metode kako bi se postiglo prikladno razluÄivanje pikova te njihov odgovarajuÄi oblik i simetrija uz Å”to kraÄe vrijeme analize.Gemcitabine, 2', 2'-difluoro-2'-deoxycytidine, pyrimidine antimetabolite, is an antineoplastic drug used to treat many advanced or metastatic cancers as monotherapy or in combination with other cytostatics, depending on the indication.
The aim of this study was to develop a new, fast, simple and environmentally friendly capillary electrophoretic method for simultaneous identification and determination of gemcitabine and its impurity cytosine. Capillary electrophoresis was chosen as a suitable "green" alternative to an already developed HPLC method for the determination of gemcitabine and its impurities included in the 8th edition of European Pharmacopoeia.
The analysis was carried out in 35 cm (27 cm) capillary at a temperature of 25 Ā° C and detection was at 275 i 237 nm. Three different buffers were studied while developing the method: borate (pH 9.3), phosphate (pH 7.0) and acetate (pH 3.0). Based on the experimental results, best buffer was shown to be the phosphate buffer (pH 7.0), while a better separation and peak shape were achieved by adding a higher concentration of SDS. 50 mM SDS was chosen as the optimal concentration. The effect of voltage on the analysis time and resolution between the analytes was investigated. It has been shown that a better separation of gemcitabine and cytosine was achieved at 10 kV. However, applying a lower voltage is prolonging the migration time of the analytes through the capillary. Therefore, it is necessary to take into account that a good resolution is achieved but that the analysis time is not too long.
Further method optimization is required to achieve the appropriate peak separation, shape and symmetry with as short analysis time as possible
The Basic Traits and an Analysis of Some Structural Changes among Croats from Žumberak in Cleveland
Prvi hrvatski doseljenici u Cleveland, Ohio, kao dio hrvatskog migracijskog vala u SAD krajem proÅ”log stoljeÄa, bili su porijeklom iz gorovitog predjela zapadne Hrvatske zvanog Žumberak. ŽumberÄani su u svijet odlazili iz specifiÄnih lokalnih razloga u podruÄju porijekla. Kao subetniÄka skupina Hrvata s vrlo razvijenom nacionalnom svijeÅ”Äu, Ävrsto povezani mitom ili realnoÅ”Äu o uskoÄkom porijeklu i pripadnoÅ”Äu grkokatoliÄkoj vjeri, u novoj su domovini stvorili svoju naseobinu koja je imala identiÄna obilježja žumberaÄke zajednice u starom kraju. (Podaci o nupcijalitetu i natalitetu iznijeti u ovom radu vrlo su indikativni u tom smislu.) Na osnovi izvornih podataka iz crkvenih knjiga hrvatske grkokatoliÄke župe Sv. Nikola u Clevelandu autorica u ovom radu analizira neke promjene u druÅ”tvenoj strukturi te homogenizirane i zatvorene žumberaÄke naseobine u vremenu od prvih doseljavanja pa do tridesetih godina ovoga stoljeÄa. Podaci i izraÄunate stope nupcijaliteta, nataliteta i mortaliteta tog prvog i dijela drugog naraÅ”taja žumberaÄkih doseljenika u Cleveland daju relativno toÄnu sliku o bitnim obilježjima i nekim strukturalnim promjenama njihove naseobine.
U radu autorica govori joÅ” o tipu žumberaÄkih migracija u Cleveland, o njihovu prostornom rasporedu u tom gradu, o druÅ”tvenom okupljanju te o ulozi hrvatske grkokatoliÄke župe Sv. Nikola u životu clevelandskih ŽumberÄana.The first Croatian immigrants in Cleveland (Ohio), coming as part of the migration wave to the USA at the end of the 19th century, originated from the mountainous region of western Croatia called Žumberak. The people of Žumberak emigrated due to specific local reasons at home. As a subethnic Croatian group with a highly developed national consciousness, closely bound together by the myth (or reality) of their origin as Uskoks fleeing from the Ottoman advance, as by their Eastern-Rite Catholic religion, in their new homeland they created settlements with identical features as in the land from which they originated. Data on marriages and natality are very indicative in this sense. On the basis of original records from the parish books of the Eastern-Rite Catholic parish of Saint Nicholas in Cleveland, the author analyses some changes in the social structure of this homogeneous and closed settlement of people from Žumberak in the period from the time of the first immigration till the 1930s. The data and calculated rates of marriages, natality and mortality of the first and a part of the second generation of migrants from Žumberak in Cleveland provide a relatively exact picture of the essential traits and some structural changes among them. In the paper, the author also notes the types of migration from Žumberak to Cleveland, the spatial distribution of the immigrants in this city, their social organisation and the role of the parish of Saint Nicholas in their lives
Cerebelarni meduloblastom u muÅ”karca starije životne dobi: neoÄekivan nalaz
Medulloblastoma is one of the most common primary tumors of the central nervous system in children and quite uncommon in adult age. Clinically, medulloblastomas may be difficult to recognize in the elderly because of their rarity and histologic similarity to common metastatic tumors. Medulloblastomas arising earlier in life occur close to the midline, whereas those arising later in life are located more laterally within a cerebellar hemisphere. This case report presents an unusual appearance of medulloblastoma in an elderly man.Meduloblastom je jedan od najÄeÅ”Äih primarnih tumora srediÅ”njeg živÄanog sustava u djeÄjoj dobi, a rijedak u odraslih osoba. Meduloblastome koji se pojavljuju u odrasloj dobi teÅ”ko je kliniÄki prepoznati zbog njihove rijetke pojavnosti i histoloÅ”ke sliÄnosti s metastatskim tumorima. Meduloblastomi koji se pojavljuju u djeÄjoj dobi smjeÅ”teni su bliže medijalnoj liniji, dok se oni koji se pojave u starijoj životnoj dobi nalaze lateralno unutar hemisfera maloga mozga. Prikazani sluÄaj predstavlja iznimno rijetku pojavu meduloblastoma u muÅ”karca starije životne dobi, koji je zahvatio gornju povrÅ”inu maloga mozga i pinealno podruÄje. VeÄina istraživanja ukazuje na to da radikalan kirurÅ”ki zahvat i poslijeoperacijsko zraÄenje imaju najbolji uÄinak na preživljenje
- ā¦